Science: Neuroprotection in Glaucoma: Old and New Promising Treatments
Entering edit mode
6 months ago
david 4.2k


Glaucoma is a major global cause of blindness, but the molecular mechanisms responsible for the neurodegenerative damage are not clear. Undoubtedly, the high intraocular pressure (IOP) and the secondary ischemic and mechanical damage of the optic nerve have a crucial role in retinal ganglion cell (RGC) death. Several studies specifically analyzed the events that lead to nerve fiber layer thinning, showing the importance of both intra- and extracellular factors. In parallel, many neuroprotective substances have been tested for their efficacy and safety in hindering the negative effects that lead to RGC death. New formulations of these compounds, also suitable for chronic oral administration, are likely to be used in clinical practice in the future along with conventional therapies, in order to control the progression of the visual impairment due to primary open-angle glaucoma (POAG). This review illustrates some of these old and new promising agents for the adjuvant treatment of POAG, with particular emphasis on forskolin and melatonin. (Dario Rusciano, 2017)

The article discusses:

  • forskolin
  • saffron (crocus sativus)
  • brimonidine and its role in neuroprotection
  • citicoline
  • homotaurine
  • carnosine
  • agomelatine
  • melatonin
  • resveratrol
  • green tea (epigallocatechin gallate)
  • coenzyme Q10
  • ginkgo biloba

Here's just a small part from the conclusion:

Ideally, the best treatment for a glaucoma patient would include a hypotonizing agent together with a neuroprotective one spanning several different molecular neurotoxic mechanisms. Melatonin and/or forskolin appear to be good candidates to be associated with a classical hypotonizing drug, preferably brimonidine, considering its own neuroprotective effects.

melatonin dietary-supplements citicoline saffron resveratrol forskolin green-tea • 253 views

Login before adding your answer.

Traffic: 27 users visited in the last hour

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.